Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
Clinical trial NCT02942277 · COMPLETED
Trial details
- NCT number
- NCT02942277
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-21
- Primary completion
- 2020-07-15
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.